MedsFacts Meta-Analysis covering adverse side effect reports of CHINOTAL (PENTOXIFYLLINE) patients who developed PHARMACEUTICAL PRODUCT COMPLAINT.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking CHINOTAL (PENTOXIFYLLINE) reported PHARMACEUTICAL PRODUCT COMPLAINT to the FDA. A total of 5 CHINOTAL (PENTOXIFYLLINE) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between CHINOTAL (PENTOXIFYLLINE) and PHARMACEUTICAL PRODUCT COMPLAINT. In doing so, we compare CHINOTAL (PENTOXIFYLLINE) with other drugs that cause PHARMACEUTICAL PRODUCT COMPLAINT, to help you evaluate whether or not CHINOTAL (PENTOXIFYLLINE) causes PHARMACEUTICAL PRODUCT COMPLAINT. Likewise, this page shows the most highly-reported side effects of CHINOTAL (PENTOXIFYLLINE), so you can see if PHARMACEUTICAL PRODUCT COMPLAINT ranks among CHINOTAL (PENTOXIFYLLINE)'s most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for CHINOTAL (PENTOXIFYLLINE) and PHARMACEUTICAL PRODUCT COMPLAINT, such as the raw number and percentage of patients in FDA reports who used CHINOTAL (PENTOXIFYLLINE) and developed PHARMACEUTICAL PRODUCT COMPLAINT. Next, the Dashboard lists the most common reasons (indications) why CHINOTAL (PENTOXIFYLLINE) was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of CHINOTAL (PENTOXIFYLLINE). This pie-chart summarizes, for all FDA reports covering CHINOTAL (PENTOXIFYLLINE), whether or not the treating physician felt CHINOTAL (PENTOXIFYLLINE) (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering CHINOTAL (PENTOXIFYLLINE). You may click on any of these side effects to learn more about them, in general, or specifically for CHINOTAL (PENTOXIFYLLINE). Finally, we identify the drugs most widely associated with CHINOTAL (PENTOXIFYLLINE) in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of CHINOTAL (PENTOXIFYLLINE) causing PHARMACEUTICAL PRODUCT COMPLAINT: 1
Reports of any side effect of CHINOTAL (PENTOXIFYLLINE) : 5
Percentage of CHINOTAL (PENTOXIFYLLINE) patients where PHARMACEUTICAL PRODUCT COMPLAINT is a reported side effect: 20%
FDA reports of any drug causing PHARMACEUTICAL PRODUCT COMPLAINT : 32129
Average percentage for all medicated patients where PHARMACEUTICAL PRODUCT COMPLAINT is reported as a complication: 0.20136560589713%
Most frequent diagnoses/indications for prescribing CHINOTAL (PENTOXIFYLLINE):
( 0 patients )
Physician opinion on CHINOTAL (PENTOXIFYLLINE) as adverse event culprit:
Most common side effects for patients taking CHINOTAL (PENTOXIFYLLINE):
MYOCARDIAL INFARCTION (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
SELF-MEDICATION (2 patients)
RENAL FAILURE (2 patients)
TONGUE PARALYSIS (1 patients)
SWELLING FACE (1 patients)
PULMONARY EMBOLISM (1 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (1 patients)
BLOOD GLUCOSE INCREASED (1 patients)
MYDRIASIS (1 patients)
Twitter feed for CHINOTAL (PENTOXIFYLLINE) - Pending/Beta
Drugs with high reportage of PHARMACEUTICAL PRODUCT COMPLAINT:
FORTEO (3551 patients)
FACTOR IX COMPLEX (3520 patients)
ANTIHEMOPHILIC FACTOR (HUMAN) (2363 patients)
ADVAIR DISKUS 100/50 (2016 patients)
ALBUTEROL (1280 patients)
ASPIRIN (1123 patients)
HUMALOG (1101 patients)
LANTUS (1054 patients)
KOATE (958 patients)
KONYNE (944 patients)
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.